Presentation GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice Presenter: Davide Capodanno July 23, 2014 REGISTER for free or LOG IN to view this content DES/BRS/DCB Factoid Up Next Presentation Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4 Presenter: Gregg W. Stone July 23, 2014 More slides + Presentation Rate of PCI for the Management of ACS and Stable CAD in the United States (2007-2011) Presenter: Luke K. Kim July 24, 2014 Presentation Association Between Clinical Presentations Before MI and Coronary Mortality Presenter: Emily Herrett July 24, 2014 We Recommend
Presentation Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4 Presenter: Gregg W. Stone July 23, 2014
Presentation Rate of PCI for the Management of ACS and Stable CAD in the United States (2007-2011) Presenter: Luke K. Kim July 24, 2014
Presentation Association Between Clinical Presentations Before MI and Coronary Mortality Presenter: Emily Herrett July 24, 2014